Testing effectiveness (Phase 2)Study completedNCT01171313
What this trial is testing
A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
Who this might be right for
Parkinson's Disease
XenoPort, Inc. 35